Desai U, Dickey B, Varani J, Kreutzer D L
Department of Pathology, University of Connecticut Health Center, Farmington 06032.
J Exp Pathol. 1984 Summer;1(3):201-16.
Recently, we have demonstrated that preformed chemotactic fragments derived from C5 (C5fr), when instilled intratracheally, induce an intense acute alveolitis. An intense intrapulmonary inflammatory reaction, characterized by accumulation of large numbers of neutrophils in the alveolar spaces, also resulted from intratracheal instillation of purified human C5. Since purified C5 does not induce PMN chemotaxis in vitro and presumably native C5 is not phlogistic in vivo, a mechanism for C5 cleavage productive of chemotactic fragments may be operative within the lung. To explore the possibility that pulmonary-mediated fragmentation of C5 occurred, both in vitro and in vivo studies were undertaken. As described in this paper, extensive cleavage of 125I-labeled C5 was demonstrated in the bronchoalveolar lavage fluids (BALF) of hamster lungs previously instilled with 125I-labeled C5. In vitro incubation of 125I-labeled C5 with normal hamster lung lavage components, cells, and lavage fluid also cleaved 125I-labeled C5. Bioassay of such in vitro reactions also revealed potent chemotactic activity for polymorphonuclear leukocytes. A potent C5-cleaving activity was detected in fluid of normal bronchoalveolar lavage (BAL) recovered from normal hamster lungs. This BALF "enzyme activity" selectively cleaved C5 in vitro, producing potent C5-related chemotactic fragmentation products, but it did not fragment C3 nor did it produce C3 chemotactic factors in vitro. Cleavage of C5 by alveolar macrophages that produces chemotactic factors has previously been attributed to an acid protease of lysosomal origin. This "enzyme activity" is apparently distinct from elastase, collagenase, and trypsin since it is not inhibited by alpha 1-antitrypsin. In separate studies, we have recently demonstrated the ability of isolated lung cells to synthesize and secrete C3 and C5 in vitro. Thus, these studies suggest that the lung may intrinsically have the capacity to regulate inflammatory reactions by the localized production of both complement components (C3 and C5) as well as complement-activating systems (e.g., C5-cleaving activity of BALF).
最近,我们已经证明,预先形成的源自C5的趋化片段(C5fr)经气管内滴注后,会引发强烈的急性肺泡炎。气管内滴注纯化的人C5也会导致强烈的肺内炎症反应,其特征是大量中性粒细胞在肺泡腔中积聚。由于纯化的C5在体外不会诱导PMN趋化,并且推测天然C5在体内没有致炎作用,因此在肺内可能存在一种产生趋化片段的C5裂解机制。为了探究肺介导的C5片段化是否发生,我们进行了体外和体内研究。如本文所述,在先前已注射125I标记的C5的仓鼠肺支气管肺泡灌洗液(BALF)中,证实了125I标记的C5发生了广泛裂解。将125I标记的C5与正常仓鼠肺灌洗成分、细胞和灌洗液进行体外孵育,也能裂解125I标记的C5。对此类体外反应的生物测定还显示出对多形核白细胞有强大的趋化活性。在从正常仓鼠肺中回收的正常支气管肺泡灌洗(BAL)液中检测到一种强大的C5裂解活性。这种BALF“酶活性”在体外选择性裂解C5,产生强大的C5相关趋化片段产物,但它不会裂解C3,在体外也不会产生C3趋化因子。肺泡巨噬细胞产生趋化因子的C5裂解作用先前被归因于溶酶体来源的酸性蛋白酶。这种“酶活性”显然不同于弹性蛋白酶、胶原酶和胰蛋白酶,因为它不受α1-抗胰蛋白酶的抑制。在单独的研究中,我们最近证明了分离的肺细胞在体外合成和分泌C3和C5的能力。因此,这些研究表明,肺可能本质上具有通过局部产生补体成分(C3和C5)以及补体激活系统(例如BALF的C5裂解活性)来调节炎症反应的能力。